A Randomized Multicentre Phase II Trial Comparing Adjuvant Therapy in Patients with Interferon Alpha-2b and 5-FU Alone or in Combination with Either External Radiation Treatment and Cisplatin (CapRI) or Radiation alone regarding Event-Free Survival – CapRI-2

BACKGROUND: The 5-year survival of patients with resected pancreatic adenocarcinoma is still unsatisfying. The ESPAC-1 and the CONKO 001 trial proofed that adjuvant chemotherapy improves 5-year survival significantly from approximately 14% to 21%. In parallel, investigators from the Virginia Mason C...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Märten, Angela, Schmidt, Jan, Ose, Jennifer, Harig, Sabine, Abel, Ulrich, Münter, Marc W, Jäger, Dirk, Friess, Helmut, Mayerle, Julia, Adler, Guido, Seufferlein, Thomas, Gress, Thomas, Schmid, Roland, Büchler, Markus W
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2009
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2696468/
https://ncbi.nlm.nih.gov/pubmed/19470159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-9-160
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados